Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer

PURPOSE: Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is used for (re)staging prostate cancer (PCa) and as a biomarker for evaluating response to therapy, but lacks established response criteria. A panel of PCa experts in nuclear medicine, rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Fanti, Stefano, Goffin, Karolien, Hadaschik, Boris A, Herrmann, Ken, Maurer, Tobias, MacLennan, Steven, Oprea-Lager, Daniela E., Oyen, Wim JG, Rouvière, Olivier, Mottet, Nicolas, Bjartell, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835167/
https://www.ncbi.nlm.nih.gov/pubmed/32617640
http://dx.doi.org/10.1007/s00259-020-04934-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835167/
https://www.ncbi.nlm.nih.gov/pubmed/32617640
http://dx.doi.org/10.1007/s00259-020-04934-4

Ejemplares similares